2.5 Å-resolution structure of human CDK-activating kinase bound to the clinical inhibitor ICEC0942.


Journal

Biophysical journal
ISSN: 1542-0086
Titre abrégé: Biophys J
Pays: United States
ID NLM: 0370626

Informations de publication

Date de publication:
16 02 2021
Historique:
received: 05 11 2020
revised: 11 12 2020
accepted: 21 12 2020
pubmed: 22 1 2021
medline: 1 6 2021
entrez: 21 1 2021
Statut: ppublish

Résumé

The human CDK-activating kinase (CAK), composed of CDK7, cyclin H, and MAT1, is involved in the control of transcription initiation and the cell cycle. Because of these activities, it has been identified as a promising target for cancer chemotherapy. A number of CDK7 inhibitors have entered clinical trials, among them ICEC0942 (also known as CT7001). Structural information can aid in improving the affinity and specificity of such drugs or drug candidates, reducing side effects in patients. Here, we have determined the structure of the human CAK in complex with ICEC0942 at 2.5 Å-resolution using cryogenic electron microscopy. Our structure reveals conformational differences of ICEC0942 compared with previous X-ray crystal structures of the CDK2-bound complex, and highlights the critical ability of cryogenic electron microscopy to resolve structures of drug-bound protein complexes without the need to crystalize the protein target.

Identifiants

pubmed: 33476598
pii: S0006-3495(21)00047-3
doi: 10.1016/j.bpj.2020.12.030
pmc: PMC7896097
pii:
doi:

Substances chimiques

Cyclin-Dependent Kinase 2 EC 2.7.11.22
Cyclin-Dependent Kinases EC 2.7.11.22
Cyclin-Dependent Kinase-Activating Kinase EC 2.7.11.22
CDK7 protein, human 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

677-686

Subventions

Organisme : NIGMS NIH HHS
ID : R35 GM127018
Pays : United States
Organisme : Howard Hughes Medical Institute
Pays : United States
Organisme : Cancer Research UK
ID : C37/A18784
Pays : United Kingdom

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2021 Biophysical Society. Published by Elsevier Inc. All rights reserved.

Références

Protein Sci. 2018 Jan;27(1):293-315
pubmed: 29067766
Nat Methods. 2017 Aug;14(8):793-796
pubmed: 28671674
Nature. 2020 Nov;587(7832):152-156
pubmed: 33087931
Mol Cell. 2015 May 21;58(4):677-89
pubmed: 26000851
Acta Crystallogr D Biol Crystallogr. 2010 Apr;66(Pt 4):486-501
pubmed: 20383002
Microscopy (Oxf). 2016 Feb;65(1):57-67
pubmed: 26705325
Proc Natl Acad Sci U S A. 2020 Sep 15;117(37):22849-22857
pubmed: 32855301
Proc Natl Acad Sci U S A. 2020 Oct 27;117(43):26739-26748
pubmed: 33055219
Structure. 2020 Nov 3;28(11):1249-1258.e2
pubmed: 32857966
J Struct Biol X. 2020 Feb 28;4:100020
pubmed: 32647824
Science. 2020 Oct 9;370(6513):223-226
pubmed: 33033219
EMBO J. 1995 Nov 15;14(22):5608-17
pubmed: 8521818
Acta Crystallogr D Struct Biol. 2020 Oct 1;76(Pt 10):912-925
pubmed: 33021493
J Struct Biol. 2012 Jul;179(1):68-75
pubmed: 22569522
J Struct Biol. 2015 Nov;192(2):216-21
pubmed: 26278980
Ultramicroscopy. 2021 Mar;222:113213
pubmed: 33524638
J Struct Biol. 2019 Jan 1;205(1):30-40
pubmed: 30502495
Nat Methods. 2017 Mar;14(3):290-296
pubmed: 28165473
IUCrJ. 2020 Feb 11;7(Pt 2):253-267
pubmed: 32148853
Elife. 2019 Apr 01;8:
pubmed: 30932812
Acta Crystallogr D Biol Crystallogr. 2009 Oct;65(Pt 10):1074-80
pubmed: 19770504
Nat Struct Biol. 1996 Oct;3(10):849-55
pubmed: 8836101
Microsc Microanal. 2008 Oct;14(5):375-9
pubmed: 18793481
IUCrJ. 2019 Jan 01;6(Pt 1):5-17
pubmed: 30713699
J Struct Biol. 2016 Aug;195(2):238-244
pubmed: 27320699
Nature. 2020 Nov;587(7832):157-161
pubmed: 33087927
Acta Crystallogr D Struct Biol. 2018 Jun 1;74(Pt 6):531-544
pubmed: 29872004
J Mol Biol. 2003 Oct 31;333(4):721-45
pubmed: 14568533
FEBS Lett. 1996 Nov 11;397(1):65-9
pubmed: 8941715
IUCrJ. 2020 Jun 11;7(Pt 4):639-643
pubmed: 32695410
Proc Natl Acad Sci U S A. 2020 Jan 14;117(2):1009-1014
pubmed: 31879346
Cancer Metastasis Rev. 2020 Sep;39(3):805-823
pubmed: 32385714
Genes Dev. 2020 Oct 15;:
pubmed: 33060135
EMBO J. 1997 Apr 1;16(7):1628-37
pubmed: 9130708
J Biol Chem. 2000 Jul 28;275(30):22815-23
pubmed: 10801852
Nat Commun. 2018 Sep 7;9(1):3628
pubmed: 30194371
Nat Commun. 2019 Mar 4;10(1):1032
pubmed: 30833564
Cell. 2017 Feb 9;168(4):629-643
pubmed: 28187285
Cell. 1994 Aug 26;78(4):713-24
pubmed: 8069918
Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):213-21
pubmed: 20124702
Structure. 2020 Nov 3;28(11):1238-1248.e4
pubmed: 32814033
Mol Cancer Ther. 2018 Jun;17(6):1156-1166
pubmed: 29545334
Elife. 2018 Nov 09;7:
pubmed: 30412051
Cell. 1995 Oct 6;83(1):47-57
pubmed: 7553872
Transcription. 2019 Apr;10(2):47-56
pubmed: 30488763
EMBO J. 1995 Oct 16;14(20):5027-36
pubmed: 7588631
ChemMedChem. 2017 Mar 7;12(5):372-380
pubmed: 28125165
Elife. 2020 Sep 14;9:
pubmed: 32924932
J Grad Med Educ. 2012 Sep;4(3):279-82
pubmed: 23997866
Nat Methods. 2017 Apr;14(4):331-332
pubmed: 28250466

Auteurs

Basil J Greber (BJ)

Division of Structural Biology, The Institute of Cancer Research, London, United Kingdom; California Institute for Quantitative Biosciences (QB3), University of California, Berkeley, Berkeley, California; Molecular Biophysics and Integrative Bio-Imaging Division, Lawrence Berkeley National Laboratory, Berkeley, California. Electronic address: basil.greber@icr.ac.uk.

Jonathan Remis (J)

California Institute for Quantitative Biosciences (QB3), University of California, Berkeley, Berkeley, California.

Simak Ali (S)

Division of Cancer, Department of Surgery & Cancer, Imperial College London, London, United Kingdom.

Eva Nogales (E)

California Institute for Quantitative Biosciences (QB3), University of California, Berkeley, Berkeley, California; Molecular Biophysics and Integrative Bio-Imaging Division, Lawrence Berkeley National Laboratory, Berkeley, California; Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, California, University of California, Berkeley, Berkeley, California; Howard Hughes Medical Institute, University of California, Berkeley, Berkeley, California.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH